Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blyth Industries (later Blyth, Inc.) was a multi-national consumer products company primarily known for its home fragrance and decorative products, such as candles. While not a traditional biotechnology or pharmaceutical firm, the company entered the health and wellness sector through its significant acquisition of ViSalus, a multi-level marketing company specializing in nutritional supplements and weight management products. Blyth's involvement in the life sciences was largely focused on the commercialization of energy drinks and dietary supplements rather than drug discovery. The company was eventually acquired by The Carlyle Group in 2015 and transitioned to private ownership.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blyth Industries.